Lyumjev U-100 Insulin

DRUG2 trials

Sponsors

Stanford University, Portal Diabetes, Inc.

Conditions

Diabetes Mellitus, Type 1Type 1 DiabetesType 1 Diabetes Mellitus

Phase 1

Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes

CompletedNCT07090824

Stanford UniversityDiabetes Mellitus, Type 1, Type 1 Diabetes Mellitus

Start: 2025-10-28End: 2026-05-29Updated: 2026-07-08

A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500

RecruitingNCT07341373

Portal Diabetes, Inc.Type 1 Diabetes

Start: 2026-02-10End: 2026-09-01Target: 25Updated: 2026-04-28